Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from John Fieldly

Celsius To Acquire Energy Drink Rival Alani Nu For $1.8 Billion; Stock Surges 21%

The purchase price consideration comprises $1,275 million of cash and a $25 million earn-out and $500 million (or approximately 22.5 million shares) of newly issued restricted shares of Celsius Holdings common stock, representing approximately 8.7% pro-forma ownership.

International Business Times

‘A troubling halo of health’: how Celsius became Red Bull for women

The energy drink with 200mg of caffeine per can has gained a cult following in the US due to its wellness-coded image

The Guardian - US

Meet the CFO-turned-CEO driving record growth for cult-favorite energy drink Celsius

John Fieldly pitched himself for the top role at the company.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

How the Celsius CEO turned a cult-favorite energy drink into a stock-market lightning rod with 6,000% growth

Celsius had 8 employees when John Fieldly took the reins. Now, it's nearing 800.

Fortune

This Is The 'Huge' Growth Opportunity For Celsius In 2024, Says CEO

IBD recently spoke to Celsius CEO John Fieldly about energy drink trends and growth drivers for the company and CELH stock in the year ahead.

Investors Business Daily

IBD 50 Stocks To Watch: Energy Drink Leader Celsius Soars Above Buy Point On Record Sales

Celsius stock on the move. The energy drink leader soared more than 20% Wednesday, breaking out past a buy point on record quarterly sales.

Investors Business Daily

Celsius CEO Embraces Wellness In His Brand And In His Life

John Fieldly runs the world's fastest-growing energy drink company. His inspiration to succeed in business, though, dates way back.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

People

Dakota Johnson

349 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

IBD 50 Stocks To Watch

23 stories

IRi

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.